Thymectomy has different goals in tumor and autoimmune disease
For a thymic epithelial tumor, surgery aims at complete en-bloc removal while protecting or deliberately managing involved structures. For selected myasthenia gravis, thymectomy may improve long-term disease control.
The extent of tumor invasion, thymus size, previous treatment and respiratory and neurologic stability determine whether minimally invasive or open access is appropriate.
Patients with myasthenia need coordinated medication, respiratory assessment and a plan for postoperative weakness or crisis.
Who may be considered?
Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about thymectomy.
- A resectable thymoma or thymic carcinoma within a multidisciplinary plan.
- Selected generalized myasthenia gravis after neurologic assessment.
- A thymic cyst or other lesion causing symptoms or diagnostic concern.
- A patient whose imaging shows a feasible complete resection.
What the specialist team must confirm
Review includes contrast CT or MRI, tumor stage and relation to vessels, pericardium and phrenic nerves, antibody and neurologic history, swallowing and breathing weakness, pulmonary tests, medicines such as pyridostigmine or immunotherapy and prior biopsy or treatment.
Key points for this treatment

From neurologic or tumor assessment to complete thymectomy
The team selects an approach that can achieve the intended extent without compromising vascular control or postoperative respiratory safety.
Neurologic benefit may take time
After surgery, breathing strength, swallowing, secretions, pain and signs of myasthenic weakness are monitored. Tumor cases follow final pathology and margin review.
Myasthenia medicines are not stopped automatically; neurologists adjust treatment according to symptoms over months or years. Cancer surveillance depends on stage and histology.

Risks, limits and realistic expectations
Risks include bleeding, infection, phrenic or recurrent-laryngeal-nerve injury, diaphragm weakness, myasthenic crisis, incomplete tumor resection, conversion to open surgery, recurrence and death.
Rapidly worsening weakness, difficulty swallowing or breathing, new voice change, fever or severe chest pain needs urgent local assessment.
